Profile
Havencrest Capital Management is a lower middle-market private equity firm based in Dallas, founded in 2018 by Christopher W. Kersey, M.D., M.B.A., a long-time healthcare investor. The firm focuses exclusively on the healthcare industry, working with a team that includes Investment Professionals, Operating Partners, and Senior Advisors. Havencrest brings together some of the nation's leading entrepreneurs, corporate executives, and public policy experts to strategically build healthcare companies that change the way healthcare is delivered in America.
Havencrest primarily invests in founder-led, high-growth, and market-leading healthcare companies. Their capital is deployed through the Havencrest Healthcare Partners II, LP, a $356M fund raised in 2022. The firm manages $600M+ in assets and has invested in various companies that drive enterprise value creation in the healthcare sector, predominantly in the United States.
Notable portfolio companies include Tekton Research, a clinical trial site network; Focus Staff, a provider of workforce solutions in healthcare; Avid Health at Home, focusing on post-acute care; Deep Centered Mental Health, a behavioral health platform; and Paradigm Health, provider of hospice and palliative care.
Industry
Havencrest Capital Management Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Havencrest Healthcare Partners I , L.P.
|
Private Equity (PE)
|
Healthcare Services
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$138 M
|
June 2017
|
|
Havencrest Healthcare Partners II, L.P
|
Private Equity (PE)
|
Healthcare Services
HealthTech
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$356 M
|
April 2022
|
Contacts
Instant access on the web. Plans from $129/month — see pricing.